Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (4571)	10/19/2000 10:06:40 AM
From: Thomas M.	Read Replies (2) \| Respond to of 10280

Thanks for your discretion. Tom

To: scott_jiminez who wrote (4571)	10/19/2000 11:25:18 AM
From: rkrw	Read Replies (1) \| Respond to of 10280

Scott--- You should consider a career as a class action attorney. Seeing your postings of the past, it seems you derive perverse pleasure in other investors losses and, of course, the all consuming "I told you so" mentality. I don't like people like you. I've been invested in Sepracor for 5+ years, added along the way and have held throughout. There's been major hiccups before no doubt they'll be more along the way. Sepracor's strategy is not static. Its been shifting dramatically from outlicensing patents for royalties to taking select drugs and developing them internally. A look at the Sepracor pipeline highlights this. They have a handful of compounds under development, many approaching the point of high visibility that late stage products attract. Risks are buffered amongst 10-20 potential drug and royalty derived products. Rewards will come from exceeding expectations on prospective drug products. I expect the company to continue to add value and reward shareholders over the long term. Take pleasure in this decline, document and point out your forewarnings, enjoy this moment, you deserve it.

To: scott_jiminez who wrote (4571)	10/19/2000 5:38:50 PM
From: Biomaven	Read Replies (2) \| Respond to of 10280

scott, I very much doubt that any SEPR executive knew anything about this Lilly action when they sold their shares. I have enough respect for the integrity of the SEPR executives that I view a sale by them as indicative of a lack of insider information. I thus see the sales as essentially "noise" and not particularly worth commenting on - any smart executive with large option grants that are substantially in the money will sell and diversify part of his or her holding. It's not as if the insider sales were some sort of secret - they are freely available and widely commented on at the Yahoo Club thread. I don't particularly like your insinuation (intended or otherwise) that I somehow didn't post the information in your PM because I thought it was adverse to my holdings. If you thought it was relevant information, you should have posted it yourself. Peter